Brind.

Applied DNA Sciences regained compliance with Nasdaq listing requirements on July 7, 2025, as a majority-owned subsidiary of LineaRx Inc.

2 reports, 0 independent Updated Jul 7

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Applied DNA Sciences regained compliance with Nasdaq listing requirements on July 7, 2025, as a majority-owned subsidiary of LineaRx Inc.

Who's involved

What this event is mainly about

Applied DNA Sciences

Keep exploring

The entities involved

Applied DNA Sciences
American high-technology company
- Countermeasures target Applied DNA Sciences' business operations following its involvement in a supply chain from Xinjiang.Fri 12:57
- MarketBeat is reporting on analyst recommendations and consensus target prices for small-cap healthcare companies Myriad Genetics and Applied DNA Sciences.Fri 11:44

Coverage

Newest first; wire copies grouped

Jul 7Unknown outlet
Jun 30Unknown outlet